Literature DB >> 7590680

The role of transjugular intrahepatic portosystemic shunt for treatment of portal hypertension and its complications: a conference sponsored by the National Digestive Diseases Advisory Board.

M L Shiffman1, L Jeffers, J H Hoofnagle, T S Tralka.   

Abstract

TIPS is a new and exciting modality for treatment of portal hypertension and its complications. Indications for TIPS remain to be better defined in terms of efficacy and cost-benefit in relationship to other established modes of therapy of portal hypertension. Prospective, randomized controlled trials are needed for these comparisons. Until the role of TIPS in the routine management of the complications of portal hypertension is better defined, TIPS should be used only in situations in which conventional medical and endoscopic therapies have failed.

Entities:  

Mesh:

Year:  1995        PMID: 7590680

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  20 in total

1.  Somatostatin plus isosorbide 5-mononitrate versus somatostatin in the control of acute gastro-oesophageal variceal bleeding: a double blind, randomised, placebo controlled clinical trial.

Authors:  F Junquera; J C López-Talavera; F Mearin; E Saperas; S Videla; J R Armengol; R Esteban; J R Malagelada
Journal:  Gut       Date:  2000-01       Impact factor: 23.059

Review 2.  Current status of transjugular intrahepatic portosystemic shunts.

Authors:  N H Patel; N Chalasani; R M Jindal
Journal:  Postgrad Med J       Date:  1998-12       Impact factor: 2.401

3.  Variceal Bleeding.

Authors: 
Journal:  Curr Treat Options Gastroenterol       Date:  1999-02

4.  Hepatorenal Syndrome.

Authors: 
Journal:  Curr Treat Options Gastroenterol       Date:  2000-12

5.  Predictors of large volume paracantesis induced circulatory dysfunction in patients with massive hepatic ascites.

Authors:  G Nasr; A Hassan; S Ahmed; A Serwah
Journal:  J Cardiovasc Dis Res       Date:  2010-07

6.  Portacaval anastomosis results in more widespread alterations of cerebral metabolism in old versus young adult rats: implications for post-shunt encephalopathy.

Authors:  R M Audet; R F Butterworth
Journal:  Metab Brain Dis       Date:  1998-03       Impact factor: 3.584

7.  Conversion of failed transjugular intrahepatic portosystemic shunt to distal splenorenal shunt in patients with Child A or B cirrhosis.

Authors:  N Selim; M J Fendley; T D Boyer; J R Galloway; G D Branum
Journal:  Ann Surg       Date:  1998-04       Impact factor: 12.969

8.  Direct intrahepatic portacaval shunt: an experimental study.

Authors:  Jian-Jun Luo; Zhi-Ping Yan; Kang-Rong Zhou; Sheng Qian
Journal:  World J Gastroenterol       Date:  2003-02       Impact factor: 5.742

Review 9.  Liver cirrhosis.

Authors:  E J Williams; J P Iredale
Journal:  Postgrad Med J       Date:  1998-04       Impact factor: 2.401

10.  Prediction of mortality after emergent transjugular intrahepatic portosystemic shunt placement: use of APACHE II, Child-Pugh and MELD scores in Asian patients with refractory variceal hemorrhage.

Authors:  Wen-Sheng Tzeng; Reng-Hong Wu; Ching-Yih Lin; Jyh-Jou Chen; Ming-Juen Sheu; Lok-Beng Koay; Chuan Lee
Journal:  Korean J Radiol       Date:  2009-08-25       Impact factor: 3.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.